{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:59:19Z","timestamp":1779292759757,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s10067-021-05797-2","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T20:02:38Z","timestamp":1624392158000},"page":"4473-4483","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4389-3083","authenticated-orcid":false,"given":"Graciela N.","family":"G\u00f3mez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00e1s","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Braillard Poccard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramiro A.","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Costi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes A.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malena","family":"Viola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Benitez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana M.","family":"Aciar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Crespo Esp\u00edndola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demelza","family":"Yucra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micaela A.","family":"Cosatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Pisoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafne","family":"Capelusnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda N.","family":"Lojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belen I.","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Kisluk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Granel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"issue":"1","key":"5797_CR1","first-page":"50","volume":"54","author":"A Meyer","year":"2014","unstructured":"Meyer A, Meyer N, Schaeffer M, Gottenberg JE, Geny B, Sibilia J (2014) Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatol (United Kingdom) 54(1):50\u201363","journal-title":"Rheumatol (United Kingdom)"},{"key":"5797_CR2","doi-asserted-by":"publisher","unstructured":"Miller FW, Lamb JA, Schmidt J, Nagaraju K. Risk factors and disease mechanisms in myositis. Nat Rev Rheumatol [Internet]. 2018;14(5):255\u201368. Available from: https:\/\/doi.org\/10.1038\/nrrheum.2018.48","DOI":"10.1038\/nrrheum.2018.48"},{"key":"5797_CR3","doi-asserted-by":"crossref","unstructured":"Li S, Ge Y, Yang H, Wang T, Zheng X, Peng Q, et al. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies. Clin Rheumatol. 2019;38(8).","DOI":"10.1007\/s10067-019-04503-7"},{"issue":"6","key":"5797_CR4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/01.bor.0000434667.55020.e1","volume":"25","author":"IE Lundberg","year":"2013","unstructured":"Lundberg IE, Svensson J (2013) Registries in idiopathic inflammatory myopathies. Curr Opin Rheumatol 25(6):729\u2013734","journal-title":"Curr Opin Rheumatol"},{"key":"5797_CR5","doi-asserted-by":"crossref","unstructured":"Anthony Bohan, M.D., and James B.Peter. P. The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on January 7, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright \u00a9 2010 Massachusetts Medical Society. All rights reserved. N Engl J Med. 1975;292(7):344\u20137.","DOI":"10.1056\/NEJM197502132920706"},{"key":"5797_CR6","doi-asserted-by":"publisher","unstructured":"Bottai M, Tj\u00e4rnlund A, Santoni G, Werth VP, Pilkington C, de Visser M, et al. EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD Open [Internet]. 2017; 3(2):e000507. Available from: https:\/\/doi.org\/10.1136\/rmdopen-2017-000507","DOI":"10.1136\/rmdopen-2017-000507"},{"issue":"6","key":"5797_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/00002281-200211000-00004","volume":"14","author":"R Tawil","year":"2002","unstructured":"Tawil R, Griggs RC (2002) Inclusion body myositis. Curr Opin Rheumatol 14(6):653\u2013657","journal-title":"Curr Opin Rheumatol"},{"key":"5797_CR8","doi-asserted-by":"publisher","unstructured":"Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest [Internet]. 2010;138(6):1464\u201374. Available from: https:\/\/doi.org\/10.1378\/chest.10-0180","DOI":"10.1378\/chest.10-0180"},{"issue":"5","key":"5797_CR9","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/bjd.17536","volume":"180","author":"JSS Concha","year":"2019","unstructured":"Concha JSS, Tarazi M, Kushner CJ, Gaffney RG, Werth VP (2019) The diagnosis and classification of amyopathic dermatomyositis: a historical review and assessment of existing criteria. Br J Dermatol 180(5):1001\u20131008","journal-title":"Br J Dermatol"},{"key":"5797_CR10","doi-asserted-by":"crossref","unstructured":"Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR, Abadi I, Caeiro F AA and A-S. The GLADEL multinational Latin American Prospective inception cohort of 1,214 patients with systemic lupus erythematosus-ethnic and disease heterogeneity among \u201cHispanics\u201d. Med.2004;83:1\u201317.","DOI":"10.1097\/01.md.0000104742.42401.e2"},{"issue":"1","key":"5797_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10067-018-4267-z","volume":"38","author":"E Zampeli","year":"2019","unstructured":"Zampeli E, Venetsanopoulou A, Argyropoulou OD, Mavragani CP, Tektonidou MG, Vlachoyiannopoulos PG et al (2019) Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies. Clin Rheumatol 38(1):125\u2013132","journal-title":"Clin Rheumatol"},{"key":"5797_CR12","doi-asserted-by":"crossref","unstructured":"Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, et al. The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis. 2018;77(1).","DOI":"10.1136\/annrheumdis-2017-211868"},{"key":"5797_CR13","doi-asserted-by":"crossref","unstructured":"Petri MH, Satoh M, Martin-Marquez BT, Vargas-Ram\u00edrez R, Jara LJ, Saavedra MA, et al. Implications in the difference of anti-Mi-2 and -p155\/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara. Arthritis Res Ther. 2013;15(2).","DOI":"10.1186\/ar4207"},{"issue":"1","key":"5797_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s12016-015-8511-x","volume":"52","author":"E Tiniakou","year":"2017","unstructured":"Tiniakou E, Mammen AL (2017) Idiopathic inflammatory myopathies and malignancy: a comprehensive review. Clin Rev Allergy Immunol 52(1):20\u201333","journal-title":"Clin Rev Allergy Immunol"},{"key":"5797_CR15","doi-asserted-by":"crossref","unstructured":"Vilela VS, Prieto-Gonz\u00e1lez S, Milisenda JC, Selva-O\u00b4Callaghan A, Grau JM. Polymyositis, a very uncommon isolated disease: clinical and histological re-evaluation after long-term follow-up. Rheumatol Int. 2015;35(5):915\u20132014","DOI":"10.1007\/s00296-014-3198-5"},{"key":"5797_CR16","unstructured":"Gomez G, Gargiulo M, Granel A y Col. M\u00e9todos de diagn\u00f3stico en el estudio de las Miopat\u00edas Inflamatorias Autoinmunes. Datos del Registro Argentino de Miopat\u00edas Inflamatorias de la Sociedad Argentina de Reumatolog\u00eda. Rev Argent Reumatol. 2020;1."},{"key":"5797_CR17","doi-asserted-by":"publisher","unstructured":"Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EKL. A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol [Internet]. 2017;52(1):1\u201319. Available from: https:\/\/doi.org\/10.1007\/s12016-015-8510-y","DOI":"10.1007\/s12016-015-8510-y"},{"key":"5797_CR18","unstructured":"Gonzalez-bello Y, Ortiz-Villalvazo MA, Garcia-Valladares I, Navarro-Zarza JE, Andrade-Ortega L, Nava-Zavala A. Study of Autoantibodies in a cohort of Mexican patients with idiopathic inflammatory myopathies. 55(Dm):17\u20139."},{"key":"5797_CR19","doi-asserted-by":"crossref","unstructured":"Cruellas MG, Viana VS, Levy-Neto M, Souza FH, Shinjo SK (2013) Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics (Sao Paulo) 68:909\u2013914","DOI":"10.6061\/clinics\/2013(07)04"},{"issue":"2","key":"5797_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/ard.60.2.116","volume":"60","author":"R Brouwer","year":"2001","unstructured":"Brouwer R, Hengstman GJD, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A et al (2001) Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60(2):116\u2013123","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5797_CR21","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1212\/01.CON.0000511070.50715.ab","volume":"22","author":"AL Mammen","year":"2016","unstructured":"Mammen AL (2016) Autoimmune myopathies. Contin Lifelong Learn Neurol 22(6):1852\u20131870","journal-title":"Contin Lifelong Learn Neurol"},{"issue":"32","key":"5797_CR22","first-page":"1","volume":"94","author":"L Cavagna","year":"2015","unstructured":"Cavagna L, Nu\u00f1o L, Scir\u00e8 CA, Govoni M, Longo FJL, Franceschini F et al (2015) Clinical spectrum time course in anti jo-1 positive antisynthetase syndrome: Results from an international retrospective multicenter study. Med (United States) 94(32):1\u20137","journal-title":"Med (United States)"},{"issue":"6","key":"5797_CR23","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/annrheumdis-2011-200182","volume":"71","author":"H Chinoy","year":"2012","unstructured":"Chinoy H, Adimulam S, Marriage F, New P, Vincze M, Zilahi E et al (2012) Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis 71(6):961\u2013965","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5797_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/1346-8138.14092","volume":"45","author":"J Li","year":"2018","unstructured":"Li J, Liu Y, Li Y, Li F, Wang K, Pan W et al (2018) Associations between anti-melanoma differentiation associated gene 5 antibody and demographics, clinical characteristics and laboratory results of patients with dermatomyositis: a systematic meta-analysis. J Dermatol 45(1):46\u201352","journal-title":"J Dermatol"},{"key":"5797_CR25","doi-asserted-by":"publisher","unstructured":"Sato Y, Otsuka K, Tamai K, Ono Y, Hamaguchi Y, Tomii K (2017) An atypical clinical course of anti-MDA5 antibody positive interstitial lung disease in a patient with three deteriorations in 9 years. Intern Med 56:341\u2013346. https:\/\/doi.org\/10.2169\/internalmedicine.56.6856","DOI":"10.2169\/internalmedicine.56.6856"},{"issue":"4","key":"5797_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","volume":"147","author":"Y Hamaguchi","year":"2011","unstructured":"Hamaguchi Y, Kuwana M, Hoshino K, Hasegawa M, Kaji K, Matsushita T et al (2011) Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol 147(4):391\u2013398","journal-title":"Arch Dermatol"},{"issue":"3","key":"5797_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3899\/jrheum.160682","volume":"44","author":"S Moghadam-Kia","year":"2017","unstructured":"Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R (2017) Antimelanoma differentiation associated gene 5 antibody: expanding the clinical spectrum in North American patients with dermatomyositis. J Rheumatol 44(3):319\u2013325","journal-title":"J Rheumatol"},{"issue":"140","key":"5797_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2018.05.010","volume":"1","author":"K Yamaguchi","year":"2018","unstructured":"Yamaguchi K, Yamaguchi A, Kashiwagi C, Sawada Y, Taguchi K, Umetsu K et al (2018 Jul) Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies. Respir Med 1(140):1\u20135","journal-title":"Respir Med"},{"issue":"1","key":"5797_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s42358-019-0071-y","volume":"59","author":"MIC Dos Passos Carvalho","year":"2019","unstructured":"Dos Passos Carvalho MIC, Shinjo SK (2019) Frequency and clinical relevance of anti-Mi-2 autoantibody in adult Brazilian patients with dermatomyositis. Adv Rheumatol (London, England) 59(1):27","journal-title":"Adv Rheumatol (London, England)"},{"issue":"8","key":"5797_CR30","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1002\/art.11090","volume":"48","author":"S Okada","year":"2003","unstructured":"Okada S, Weatherhead E, Targoff IN, Wesley R, Miller FW (2003) Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum 48(8):2285\u20132293","journal-title":"Arthritis Rheum"},{"issue":"8","key":"5797_CR31","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/art.24702","volume":"60","author":"LA Love","year":"2009","unstructured":"Love LA, Weinberg CR, Mc Connaughey DR, Oddis CV, Medsger TA, Reveille JD et al (2009) Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis Rheum 60(8):2499\u20132504","journal-title":"Arthritis Rheum"},{"issue":"7","key":"5797_CR32","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00296-016-3494-3","volume":"36","author":"P Srivastava","year":"2016","unstructured":"Srivastava P, Dwivedi S, Misra R (2016) Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis. Rheumatol Int 36(7):935\u2013943","journal-title":"Rheumatol Int"},{"issue":"7","key":"5797_CR33","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/art.1780280711","volume":"28","author":"IN Targoff","year":"1985","unstructured":"Targoff IN, Reichlin M (1985) The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 28(7):796\u2013803","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5797_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5114\/reum.2016.58756","volume":"54","author":"A Masiak","year":"2016","unstructured":"Masiak A, Kulczycka J, Czuszy\u0144ska Z, Zdrojewski Z (2016) Clinical characteristics of patients with anti- TIF1-\u03b3 antibodies. Reumatologia 54(1):14\u201318","journal-title":"Reumatologia"},{"issue":"2","key":"5797_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/acr.22920","volume":"69","author":"I Pinal-Fernandez","year":"2017","unstructured":"Pinal-Fernandez I, Parks C, Werner JL, Albayda J, Paik J, Danoff SK et al (2017) Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle. Arthritis Care Res 69(2):263\u2013270","journal-title":"Arthritis Care Res"},{"issue":"4","key":"5797_CR36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.nmd.2014.01.002","volume":"24","author":"L Wang","year":"2014","unstructured":"Wang L, Liu L, Hao H, Gao F, Liu X, Wang Z et al (2014) Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients. Neuromuscul Disord 24(4):335\u2013341","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"5797_CR37","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","volume":"87","author":"Y Watanabe","year":"2016","unstructured":"Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K et al (2016) Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. J Neurol Neurosurg Psychiatry 87(10):1038\u20131044","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5797_CR38","doi-asserted-by":"crossref","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-mediated necrotizing myopathy. Vol. 20, Current Rheumatology Reports. 2018.","DOI":"10.1007\/s11926-018-0732-6"},{"issue":"5","key":"5797_CR39","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/CIRCULATIONAHA.112.118877","volume":"127","author":"M Thi\u00e9baut","year":"2013","unstructured":"Thi\u00e9baut M, Terrier B, Menacer S, Berezne A, Bussone G, Goulvestre C et al (2013) Antisignal recognition particle antibodies-related cardiomyopathy. Circulation 127(5):434\u2013436","journal-title":"Circulation"},{"key":"5797_CR40","doi-asserted-by":"publisher","unstructured":"Palterer B, Vitiello G, Carraresi A, Giudizi MG, Cammelli D, Parronchi P. Bench to bedside review of myositis autoantibodies. Clin Mol Allergy [Internet]. 2018;16(1):1\u201317. Available from: https:\/\/doi.org\/10.1186\/s12948-018-0084-9","DOI":"10.1186\/s12948-018-0084-9"},{"key":"5797_CR41","doi-asserted-by":"publisher","unstructured":"Aggarwal R, Cassidy E, Fertig N, Koontz DC, Lucas M, Ascherman D et al (2014) Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse\u00a0survival than Jo-1 positive patients. Ann Rheum Dis 73(1):227\u2013232. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201800","DOI":"10.1136\/annrheumdis-2012-201800"},{"issue":"12","key":"5797_CR42","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.011","volume":"13","author":"L Bodoki","year":"2014","unstructured":"Bodoki L, Nagy-Vincze M, Griger Z, Betteridge Z, Sz\u00f6llosi L, Dank\u00f3 K (2014) Four dermatomyositis-specific autoantibodies-anti-TIF1\u03b3, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort. Autoimmun Rev 13(12):1211\u20131219","journal-title":"Autoimmun Rev"},{"key":"5797_CR43","doi-asserted-by":"publisher","unstructured":"Tarricone E, Ghirardello A, Rampudda M, Bassi N, Punzi L, Doria A. Anti-SAE antibodies in autoimmune myositis: Identification by unlabelled protein immunoprecipitation in an Italian patient cohort. J Immunol Methods [Internet]. 2012;384(1\u20132):128\u201334. Available from: https:\/\/doi.org\/10.1016\/j.jim.2012.07.019","DOI":"10.1016\/j.jim.2012.07.019"},{"key":"5797_CR44","doi-asserted-by":"publisher","unstructured":"Zhong L, Yu Z, Song H. Association of anti-nuclear matrix protein 2 antibody with complications in patients with idiopathic inflammatory myopathies: a meta-analysis of 20 cohorts. Clin Immunol [Internet]. 2019;198:11\u20138. Available from: https:\/\/doi.org\/10.1016\/j.clim.2018.11.008","DOI":"10.1016\/j.clim.2018.11.008"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05797-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05797-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05797-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T13:09:45Z","timestamp":1634389785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05797-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["5797"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05797-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"assertion":[{"value":"18 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Registry has the approval of the Teaching and Research Committee and the Ethics Committee of the Instituto de Investigaciones M\u00e9dicas Alfredo Lanari, of the Universidad de Buenos Aires (UBA).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Subjects who were entered into the Registry must have to sign an informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}